333 related articles for article (PubMed ID: 10092648)
21. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
[TBL] [Abstract][Full Text] [Related]
22. NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains.
Schnur E; Kessler N; Zherdev Y; Noah E; Scherf T; Ding FX; Rabinovich S; Arshava B; Kurbatska V; Leonciks A; Tsimanis A; Rosen O; Naider F; Anglister J
FEBS J; 2013 May; 280(9):2068-84. PubMed ID: 23480650
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
[TBL] [Abstract][Full Text] [Related]
25. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
[TBL] [Abstract][Full Text] [Related]
26. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.
Blanpain C; Vanderwinden JM; Cihak J; Wittamer V; Le Poul E; Issafras H; Stangassinger M; Vassart G; Marullo S; Schlndorff D; Parmentier M; Mack M
Mol Biol Cell; 2002 Feb; 13(2):723-37. PubMed ID: 11854425
[TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
Alsmadi O; Tilley SA
J Virol; 1998 Jan; 72(1):286-93. PubMed ID: 9420226
[TBL] [Abstract][Full Text] [Related]
28. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
[TBL] [Abstract][Full Text] [Related]
29. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
30. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins.
Hill CM; Kwon D; Jones M; Davis CB; Marmon S; Daugherty BL; DeMartino JA; Springer MS; Unutmaz D; Littman DR
Virology; 1998 Sep; 248(2):357-71. PubMed ID: 9721244
[TBL] [Abstract][Full Text] [Related]
31. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
[TBL] [Abstract][Full Text] [Related]
32. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
Platt EJ; Kuhmann SE; Rose PP; Kabat D
J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
[TBL] [Abstract][Full Text] [Related]
33. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
34. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
Dragic T; Trkola A; Lin SW; Nagashima KA; Kajumo F; Zhao L; Olson WC; Wu L; Mackay CR; Allaway GP; Sakmar TP; Moore JP; Maddon PJ
J Virol; 1998 Jan; 72(1):279-85. PubMed ID: 9420225
[TBL] [Abstract][Full Text] [Related]
35. Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.
Ray-Saha S; Huber T; Sakmar TP
Biochemistry; 2014 Mar; 53(8):1302-10. PubMed ID: 24490954
[TBL] [Abstract][Full Text] [Related]
36. Recognition of RANTES by extracellular parts of the CCR5 receptor.
Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
[TBL] [Abstract][Full Text] [Related]
37. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
[TBL] [Abstract][Full Text] [Related]
38. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
Platt EJ; Shea DM; Rose PP; Kabat D
J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
[TBL] [Abstract][Full Text] [Related]
39. Molecular modeling of HIV-1 coreceptor CCR5 and exploring of conformational space of its extracellular domain in molecular dynamics simulation.
Efremov RG; Legret F; Vergoten G; Capron A; Bahr GM; Arseniev AS
J Biomol Struct Dyn; 1998 Aug; 16(1):77-90. PubMed ID: 9745897
[TBL] [Abstract][Full Text] [Related]
40. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
Melikyan GB; Platt EJ; Kabat D
Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
